+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Lung Cancer Drugs Market Research Reports

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 85 Pages
From
Global Lung Cancer Partnering 2010 to 2017 - Product Thumbnail Image

Global Lung Cancer Partnering 2010 to 2017

  • Report
  • March 2017
  • 150 Pages
From
From
From
Global Lung Cancer Therapeutics Market 2016-2020 - Product Thumbnail Image

Global Lung Cancer Therapeutics Market 2016-2020

  • Report
  • November 2016
  • 101 Pages
From
From
Etoposide (CAS 33419-42-0) Market Research Report 2017 - Product Thumbnail Image

Etoposide (CAS 33419-42-0) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator
adroll